Eosinophilic pneumonia

D.J. Hendrick and G.P. Spickett

in Oxford Textbook of Medicine

Fifth edition

Published on behalf of Oxford University Press

ISBN: 9780199204854
Published online May 2012 | e-ISBN: 9780199570973 | DOI:

Series: Oxford Textbooks

Eosinophilic pneumonia

More Like This

Show all results sharing this subject:

  • Respiratory Medicine and Pulmonology


Show Summary Details


Eosinophilic pneumonia occurs when alveolar spaces are consolidated because of eosinophil inflammation/infiltration, usually with an accompanying eosinophilia of peripheral blood. The diagnosis should be considered when infiltrates on a chest radiograph, often migratory, are associated with blood eosinophilia, and confirmed by demonstrating an excess of eosinophils in bronchoalveolar lavage fluid.

Aetiology—before concluding that the cause is ‘idiopathic’, the following must be considered: (1) parasitic infestation; (2) adverse drug reaction; (3) asthma; (4) allergic bronchopulmonary mycosis; (5) vasculitis; (6) hypereosinophilic syndrome; and (7) other disorders known to be associated with eosinophilic pneumonia.

Acute eosinophilic pneumonia (Löffler’s syndrome)—transitory migratory pulmonary shadows associated with modest peripheral eosinophilia in patients with a mild self-limiting illness. Patients are often atopic. May be an allergic reaction to blood-borne parasites (particularly Ascaris lumbricoides) or drugs.

Chronic eosinophilic pneumonia—pulmonary shadows, typically peripheral, persist for more than 1 month and are often associated with systemic symptoms (particularly fever). May result in diffuse fibrosis or fixed airway obstruction, or both.

Eosinophilic pneumonia with asthma—may be associated with fungal hypersensitivity (commonly Aspergillus fumigatus, i.e allergic bronchopulmonary aspergillosis) or Churg–Strauss syndrome (a vasculitic and granulomatous disorder).

Tropical eosinophilia—due to migrating larvae of filarial worms (Wucheria bancrofti, Brugia malayi). Chronic cases may develop pulmonary fibrosis.

Hypereosinophilic syndrome—when eosinophilic pneumonia (and infiltrative eosinophilic disorders of other organs) is not comfortably classified by any other diagnostic category. Two mechanisms may explain many cases: (1) a genetic deletion creating a protein with tyrosine kinase activity that affects myeloid differentiation (responds to imatinib); (2) a lymphocytic variant where an abnormal clone of T-cells releases ‘eosinophilic’ cytokines.

Causal factors need to be treated, but eosinophilic pneumonia otherwise often responds well to corticosteroid medication.

Chapter.  2866 words.  Illustrated.

Subjects: Respiratory Medicine and Pulmonology

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.